MedPath

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

Not Applicable
Recruiting
Conditions
Tinea Capitis
Interventions
Registration Number
NCT07184203
Lead Sponsor
Alexandria University
Brief Summary

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria

• Tinea capitis patients with ages ranging from 5 to 18 year

Exclusion Criteria
  • Patients with contraindications to itraconazole
  • Patients with associated scalp disease.
  • Patients weighing less than 20 Kg.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A will receive itraconazole continuous daily regimenItraconazole (ITZ)-
Group B will receive itraconazole pulse regimenItraconazole (ITZ)-
Primary Outcome Measures
NameTimeMethod
improvement of tinea capitis3 months

cure of tinea capitis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine

🇪🇬

Alexandria, Egypt

Faculty of Medicine
🇪🇬Alexandria, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.